Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2025-12-25 @ 2:50 AM
NCT ID:
NCT07107633
Eligibility Criteria:
Inclusion Criteria:
Only those who meet all the following requirements are eligible to join the group:
1. Adults over 18 years of age (based on the time when the informed consent form was signed) can be male or female;
2. Subjects with gastrointestinal malignant tumor confirmed by histology/cytology;
3. Subjects to be surgically removed or explored;
4. The estimated survival time is ≥12 weeks;
5. Subjects of childbearing age agreed to adopt effective contraceptive measures during the study period;
6. Subjects fully understand the purpose, nature, methods and possible adverse reactions of the experiment, voluntarily participate in and sign a written informed consent, and are willing to follow the requirements of the protocol to complete the study.riteria:
Those who meet one of the following items are not allowed to join the group:
1. According to the researcher's judgment, during the screening period, from the imaging examination to the comprehensive real diagnosis information result, the patients were treated with anti-digestive tract tumor;
2. symptomatic brain metastases who need treatment;
3. Have serious cardiovascular and cerebrovascular diseases;
4. There are other contraindications for imaging examination of the research plan, such as claustrophobia;
5. Have a history of other malignant tumors;
6. Pregnant (pregnancy test positive in screening period) or lactating women;
7. Other circumstances that the researcher considers inappropriate to participate in this clinical trial.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07107633
Study Brief:
Protocol Section:
NCT07107633